NEXENTIS TECHNOLOGIES INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NEXENTIS TECHNOLOGIES INC. (NXTS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $70.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-13
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $70.00K.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $90.00K.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-06-30 was $5.79K, a 11.78% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-03-31 was $691.22K, a 5746.90% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $91.00K, a 9000.00% increase from fiscal 2024.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.00K.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $223.22K, a 54.69% decline from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $492.62K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $70.00K 10-Q · filed 2026-08-13 | $160.00K derived: sum of 2 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $90.00K 10-Q · filed 2026-08-13 | |||
| 2025-12-31 | $91.00K 10-K · filed 2026-03-31 | |||
| 2024-12-31 | $1.00K 10-K · filed 2026-03-31 | |||
| 2023-06-30 | $5.79K 10-Q · filed 2024-11-14 | $697.01K derived: sum of 2 quarters · filed 2024-11-14 | ||
| 2023-03-31 | $691.22K 10-Q · filed 2024-05-15 | |||
| 2022-06-30 | $5.18K 10-Q · filed 2022-11-14 | $17.00K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2022-03-31 | $11.82K 10-Q · filed 2022-11-14 | |||
| 2021-12-31 | $223.22K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $56.91K 10-Q · filed 2022-11-14 | $118.47K derived: sum of 2 quarters · filed 2022-11-14 | $202.97K derived: sum of 3 quarters · filed 2022-11-14 | |
| 2021-06-30 | $61.56K 10-Q · filed 2022-11-14 | $146.06K derived: sum of 2 quarters · filed 2022-11-14 | ||
| 2021-03-31 | $84.50K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $492.62K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $168.82K 10-Q · filed 2021-11-15 | $353.09K derived: sum of 2 quarters · filed 2021-11-15 | $388.49K derived: sum of 3 quarters · filed 2021-11-15 | |
| 2020-06-30 | $184.26K 10-Q · filed 2021-11-15 | $219.67K derived: sum of 2 quarters · filed 2021-11-15 | ||
| 2020-03-31 | $35.40K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |